The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

Frustrated parents and other concerned residents who packed a Sanborn Regional School Board meeting Wednesday night expressed ...

New York State lawmakers led by Minority Leader Ortt, Sens. Chan, Weber and Martins, launched bills to fix the MTA amid cost ...

President of the Senate, Godswill Akpabio, has refuted accusations that he instigated the removal of the erstwhile Senator representing Adamawa North, Elisha Abbo, from the Red Chamber. Abbo was ...

Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to ...

Ouster's growth potential, competitive edge, and strong financial outlook make it a top buy, with a $27 target. Learn why ...

Ouster is a high-growth LiDAR technology company with a strong balance sheet, but breakeven is still several years away. Read ...

The Town of Tonawanda has formally accused members of its police force of violating the state's Taylor Law by participating ...

By Manas Mishra (Reuters) -Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug ...

On Monday, Ouster stock earned a positive adjustment to its Relative Strength (RS) Rating, from 80 to 95. IBD's proprietary RS Rating identifies technical performance by using a 1 (worst ...

Hailed for his offensive talents, he quickly became the Rangers’ top prospect after the organization drafted him No. 23 ...